Vaccination and treatment options for SARS-CoV2 infection affecting lactation and breastfeeding

被引:4
作者
Chen, Melissa J. [1 ]
Cheema, Ritu [2 ]
Hoyt-Austin, Adrienne [3 ]
Agnoli, Alicia [4 ]
Kuhn-Riordon, Kara [5 ]
Kair, Laura R. [6 ]
机构
[1] Univ Calif Davis, Dept Obstet & Gynecol, 4860 & St,Suite 2500, Sacramento, CA 95817 USA
[2] Univ Calif Sacramento, UC Davis Childrens Hosp, Sch Med, Dept Pediat,Div Pediat Infect Dis, 2315 Stockton Blvd, Sacramento, CA 95817 USA
[3] Dept Pediat, Div Gen Pediat, 2516 Stockton Blvd,Ticon 2, Sacramento, CA 95817 USA
[4] Dept Family & Community Med, 4860 Y St,Suite 1600, Sacramento, CA 95817 USA
[5] Dept Pediat, Div Neonatol, 2516 Stockton Blvd, Sacramento, CA 95817 USA
[6] Dept Pediat, 2521 Stockton Blvd, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
COVID-19; SARS-CoV2; Breastfeeding; Lactation; Vaccination; Therapeutics; SAFETY;
D O I
10.1016/j.siny.2023.101425
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The COVID-19 pandemic has posed considerable challenges to the health of lactating individuals. Vaccination remains one of the most important strategies for prevention of moderate to severe COVID-19 infection and is associated with protective benefits for lactating individuals and their breastfed infants with overall mild side effects. The current recommendations for COVID-19 treatment in lactating individuals includes remdesivir and dexamethasone for hospitalized patients and Paxlovid (R)(nirmatrelavir + ritonavir) as outpatient treatment in those with mild disease. As the pandemic continues to evolve with new COVID-19 variants, alternative therapeutic options are potentially needed, and it is critical to include lactating individuals in research to evaluate the safety and efficacy of COVID-19 treatment options in this population.
引用
收藏
页数:6
相关论文
共 46 条
[1]   Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis [J].
Allotey, John ;
Stallings, Elena ;
Bonet, Mercedes ;
Yap, Magnus ;
Chatterjee, Shaunak ;
Kew, Tania ;
Debenham, Luke ;
Llavall, Anna Clave ;
Dixit, Anushka ;
Zhou, Dengyi ;
Balaji, Rishab ;
Lee, Siang Ing ;
Qiu, Xiu ;
Yuan, Mingyang ;
Coomar, Dyuti ;
van Wely, Madelon ;
van Leeuwen, Elizabeth ;
Kostova, Elena ;
Kunst, Heinke ;
Khalil, Asma ;
Tiberi, Simon ;
Brizuela, Vanessa ;
Broutet, Nathalie ;
Kara, Edna ;
Kim, Caron Rahn ;
Thorson, Anna ;
Oladapo, Olufemi T. ;
Mofenson, Lynne ;
Zamora, Javier ;
Thangaratinam, Shakila .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
[2]  
American Academy of Family Physicians, STAT STRONG MED CONS
[3]  
American Academy of Pediatrics, FAQS MAN INF BORN MO
[4]  
American Academy of Pediatrics, BREASTF COVID 19 PAN, DOI [10.1542/ppe_document201/418/Breastfeeding-During-the-COVID-19-Pandemic?autologincheck=redirected, DOI 10.1542/PPE_DOCUMENT201/418/BREASTFEEDING-DURING-THE-COVID-19-PANDEMIC?AUTOLOGINCHECK=REDIRECTED]
[5]  
American College of Obstetricians and Gynecologists, PRACT ADV COVID 19 V
[6]   COVID-19 Drugs and Breastfeeding Update [J].
Anderson, Philip O. .
BREASTFEEDING MEDICINE, 2022, 17 (05) :377-379
[7]   Maternal and Infant Outcomes Associated with Maternity Practices Related to COVID-19: The COVID Mothers Study [J].
Bartick, Melissa C. ;
Valdes, Veronica ;
Giusti, Angela ;
Chapin, Elise M. ;
Bhana, Nikhil B. ;
Hernandez-Aguilar, Maria-Teresa ;
Duarte, Elysangela Dittz ;
Jenkins, Lucia ;
Gaughan, John ;
Feldman-Winter, Lori .
BREASTFEEDING MEDICINE, 2021, 16 (03) :189-199
[8]   Maternal and Child Outcomes Reported by Breastfeeding Women Following Messenger RNA COVID-19 Vaccination [J].
Bertrand, Kerri ;
Honerkamp-Smith, Gordon ;
Chambers, Christina D. .
BREASTFEEDING MEDICINE, 2021, 16 (09) :697-701
[9]  
Center for Drug Evaluation and Research, 2018, 207924 NDA CTR DRUG
[10]  
Centers for Disease Control and Prevention, COVID 19 VACC PREGN